The patient-centred subscale of the questionnaire tapped into patient-related factors that
may influence psychiatrists’ prescription patterns. Questions in this subscale included patients and relatives’ acceptance of LAIs, which we hypothesised would significantly affect prescribing patterns. Patient preferences have been found to influence clinicians’ tendency to prescribe LAIs [Patel and David, 2005; Patel et al. 2009; Heres et al. 2011]. We also noted that psychiatrists who prescribed LAIs less frequently were more likely to believe that depots were coercive. This alludes to the negative ‘image’ of LAIs [Mahadun and Marshall, 2008] which is likely to adversely affect LAI utilisation Inhibitors,research,lifescience,medical and promote stigma [Patel et al. 2010b]. In contrast to a similar study among psychiatrists in the UK [Patel et al. 2010a], we observed a significant relationship between psychiatrists’
personal dislike for injections Inhibitors,research,lifescience,medical and higher mean scores on the patient-centred subscale. This might suggest that respondents who disliked injections would tend to prescribe them less, believing that patients may dislike injections themselves. Studies examining the attitudes of patients and their caregivers in developing countries towards LAIs and factors Inhibitors,research,lifescience,medical influencing LAI prescribing are needed. One wonders whether erroneous beliefs about the potency of parenteral medications over oral medications might positively influence acceptance of LAIs. Furthermore, methods by which medication choice can best be offered need further exploration as high illiteracy rates Inhibitors,research,lifescience,medical and low earning power are commonplace. Conclusion This study reveals that senior Inhibitors,research,lifescience,medical trainees and consultant psychiatrists in Selleckchem Tacedinaline Nigeria report a high utilisation rate for LAIs. Although they hold positive views about LAIs, their knowledge concerning LAIs was only fair and should be updated. Although it was mostly agreed that LAIs significantly reduced relapse rates, patient-centred factors were found to be significant in influencing prescribing rates for
LAIs. Acknowledgments The authors would like to thank Dr B. Ola and Dr J. Abdulmalik for their assistance with the collection of data. Footnotes Funding: This research received of no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Conflict of interest statement: The authors declare no conflicts of interest in preparing this article. Contributor Information Bawo O. James, Federal Psychiatric Hospital, Ugbowo Lagos Road, Benin City, 30001, Nigeria. Joyce O. Omoaregba, Federal Psychiatric Hospital, Benin City, Nigeria. Kingsley M. Okonoda, Jos University Teaching Hospital, Jos, Nigeria. Edebi U. Otefe, Neuropsychiatric Hospital Aro, Abeokuta, Nigeria. Maxine X. Patel, Kings College London, London, UK.